Researchers sought to compare the quality of care provided by advanced practice providers with cardiologists for patients in a post-percutaneous coronary intervention setting.
Researchers sought to investigate the association between proton pump inhibitor use and cause-specific mortality in US Veterans.
A history of mild liver disease is associated with a higher risk for bleeding during anticoagulation therapy but does not change the relative efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation.
Young adult LDL ≥100 mg/dL tied to 64% increased risk for CHD, independent of later levels.
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
Fasting, nonfasting levels show similar associations with cardiovascular events even for patients on statins.
Further studies are needed to determine the threshold of risk at which it is safe to withhold therapy for prevention of atherosclerotic cardiovascular disease in elderly people.
Higher percent trunk fat and lower percent leg fat linked to increased risk of cardiovascular disease.
The safety and efficacy of direct oral anticoagulants were associated with significant overall reductions in mortality in venous thromboembolism compared with observation alone.
Regular assessment of adherence to blood pressure-lowering drugs as well as directly observed therapy may be helpful for resolving treatment-resistant hypertension.
